Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 04 Oct 2022

Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study

in Pharmacology of Anti-Cancer Drugs

Ryota Tashiro
Hitoshi Kawazoe
Kanako Mamishin
Keisuke Seto
Ryoko Udagawa
Yoshimasa Saito
Hironobu Hashimoto
Tatsunori Shimoi
Kan Yonemori
Masahito Yonemura

Frontiers in Oncology

doi 10.3389/fonc.2022.898150

4,899 views
7 citations

Original Research

Published on 30 Sep 2022

Huaier suppresses pancreatic cancer progression via activating cell autophagy induced ferroptosis

in Pharmacology of Anti-Cancer Drugs

Zeen Zhu
Xueni Wang
Wunai Zhang
Mengyuan Gong
Simei Zhang
Bao Yang
Bolun Qu
Zheng Wu
Qingyong Ma
Zheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.960858

6,279 views
15 citations

Original Research

Published on 29 Sep 2022

The role and therapeutic significance of the anoikis pathway in renal clear cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Jin Wang
Xiaochen Qi
Qifei Wang
Guangzhen Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.1009984

4,020 views
9 citations

Case Report

Published on 29 Sep 2022

Case report: Different mechanisms of drug resistance in a synchronous multiple primary lung cancer patient after EGFR-TKI treatment

in Pharmacology of Anti-Cancer Drugs

Shaonan Xie
Qingyi Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.977065

1,646 views
1 citation

Original Research

Published on 29 Sep 2022

Global research trends and hotspots on glioma stem cells

in Pharmacology of Anti-Cancer Drugs

Sirong Song
Haiyang Wu
Fanchen Wang
Jiji Jiao
Lixia Xu
Hongguang Wang
Xiaoguang Tong
Hua Yan

Frontiers in Oncology

doi 10.3389/fonc.2022.926025

4,145 views
9 citations

Review

Published on 27 Sep 2022

A research update on the antitumor effects of active components of Chinese medicine ChanSu

in Pharmacology of Anti-Cancer Drugs

Jinhao Jia
Jie Li
Qiusheng Zheng
Defang Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1014637

6,979 views
26 citations

Review

Published on 26 Sep 2022

Conducive target range of breast cancer: Hypoxic tumor microenvironment

in Pharmacology of Anti-Cancer Drugs

Wen Cheng
Xian Xiao
Yang Liao
Qingqing Cao
Chaoran Wang
Xiaojiang Li
Yingjie Jia

Frontiers in Oncology

doi 10.3389/fonc.2022.978276

3,758 views
9 citations

Original Research

Published on 23 Sep 2022

Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics

in Pharmacology of Anti-Cancer Drugs

Yuan Shu
Jie Peng
Zuxi Feng
Kaibo Hu
Ting Li
Peijun Zhu
Tao Cheng
Liang Hao

Frontiers in Oncology

doi 10.3389/fonc.2022.941724

4,876 views
15 citations

Original Research

Published on 23 Sep 2022

MOF negatively regulates estrogen receptor α signaling via CUL4B-mediated protein degradation in breast cancer

in Pharmacology of Anti-Cancer Drugs

Xu Zhang
Yang Yang
Danyang Li
Zhen Wu
Haoyu Liu
Ziyan Zhao
Hongying Zhu
Fei Xie
Xiangzhi Li

Frontiers in Oncology

doi 10.3389/fonc.2022.868866

11,158 views
4 citations

Review

Published on 23 Sep 2022

Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Massimiliano Salati
Francesco Caputo
Alessandro Bocconi
Sara Cerri
Cinzia Baldessari
Federico Piacentini
Massimo Dominici
Fabio Gelsomino

Frontiers in Oncology

doi 10.3389/fonc.2022.993573

3,636 views
5 citations

Correction

Published on 22 Sep 2022

Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity

in Pharmacology of Anti-Cancer Drugs

Jamila Mammadova
Anna Redden
Rachel Cruz
Boglarka Ujhazi
Sumai Gordon
Maryssa Ellison
Tyra Gatewood
Carla Duff
Anthony Cannella
Charurut Somboonwit

Frontiers in Oncology

doi 10.3389/fonc.2022.1007616

1,294 views

Original Research

Published on 21 Sep 2022

The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Binxiang Chu
Zhenghua Hong
Xiaohe Zheng

Frontiers in Oncology

doi 10.3389/fonc.2022.925411

4,397 views
6 citations

Original Research

Published on 20 Sep 2022

Construction of immune cell infiltration protein network based on clinical low grade glioma cases

in Pharmacology of Anti-Cancer Drugs

Wei Jiang
Zijian He
Weizhong Jiang
Jiarui Du
Lutao Yuan
Cong Luo
Xiang Li
Fulin Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.956348

1,584 views
1 citation

Review

Published on 20 Sep 2022

Natural products exert anti-tumor effects by regulating exosomal ncRNA

in Pharmacology of Anti-Cancer Drugs

Shuang Hu
Yi Liu
Shuguang Guan
Zhidong Qiu
Da Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1006114

2,604 views
8 citations

Original Research

Published on 20 Sep 2022

Comprehensive analysis of m6A-modified circRNAs in peritoneal metastasis of high grade serious carcinoma of ovary

in Pharmacology of Anti-Cancer Drugs

Lin Guo
Nini Xu
Daner Qiu
Xiaozhe Yang
Shasha Zhao
Hongxi Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.988578

2,469 views
1 citation

Systematic Review

Published on 16 Sep 2022

Microenvironment immune response induced by tumor ferroptosis—the application of nanomedicine

in Pharmacology of Anti-Cancer Drugs

Tian Yun
Zhenzhu Liu
Jianbo Wang
Rui Wang
Liang Zhu
Zheng Zhu
Xuejian Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1019654

3,353 views
10 citations